Publication:
The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases

Simple item page
dc.contributor.buuauthorEker, Salih Saygın
dc.contributor.buuauthorSarandol, Aslı
dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorSivrioğlu, Enver Yusuf
dc.contributor.buuauthorKırlı, Selçuk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPsikiyatri Ana Bilim Dalı
dc.contributor.researcheridQ-9477-2019
dc.contributor.scopusid14019347700
dc.contributor.scopusid14020405100
dc.contributor.scopusid14061855100
dc.contributor.scopusid14062563200
dc.contributor.scopusid14019745700
dc.date.accessioned2022-01-26T06:44:26Z
dc.date.available2022-01-26T06:44:26Z
dc.date.issued2009-11
dc.description.abstractQTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment.
dc.identifier.citationEker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996.
dc.identifier.endpage996
dc.identifier.issn0269-8811
dc.identifier.issue8
dc.identifier.pubmed18635710
dc.identifier.scopus2-s2.0-70449419969
dc.identifier.startpage993
dc.identifier.urihttps://doi.org/10.1177/0269881108093843
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/0269881108093843
dc.identifier.urihttp://hdl.handle.net/11452/24297
dc.identifier.volume23
dc.identifier.wos000271496000018
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSage Publications
dc.relation.journalJournal of Psychopharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntipsychotic
dc.subjectQTc prolongation
dc.subjectZiprasidone
dc.subjectTorsade-de-pointes
dc.subjectSchizoaffective disorder
dc.subjectAntipsychotic-drugs
dc.subjectAcute exacerbation
dc.subjectDouble-blind
dc.subject160 mg/day
dc.subjectSchizophrenia
dc.subjectSafety
dc.subjectHaloperidol
dc.subjectManagement
dc.subjectNeurosciences & neurology
dc.subjectPharmacology & pharmacy
dc.subjectPsychiatry
dc.subject.emtreeAmisulpride
dc.subject.emtreeBiperiden
dc.subject.emtreeBornaprine
dc.subject.emtreeGlimepiride
dc.subject.emtreeHaloperidol
dc.subject.emtreeLithium
dc.subject.emtreeMetformin
dc.subject.emtreeQuetiapine
dc.subject.emtreeValproic acid
dc.subject.emtreeVenlafaxine
dc.subject.emtreeZiprasidone
dc.subject.emtreeZuclopenthixol decanoate
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeCase report
dc.subject.emtreeDiabetes mellitus
dc.subject.emtreeDiagnostic and statistical manual of mental disorders
dc.subject.emtreeDisease exacerbation
dc.subject.emtreeDrug blood level
dc.subject.emtreeDrug dose increase
dc.subject.emtreeDrug dose reduction
dc.subject.emtreeDrug efficacy
dc.subject.emtreeDrug response
dc.subject.emtreeDrug substitution
dc.subject.emtreeDrug withdrawal
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeMale
dc.subject.emtreePriority journal
dc.subject.emtreePsychosis
dc.subject.emtreeQT prolongation
dc.subject.emtreeSchizophrenia
dc.subject.meshAdult
dc.subject.meshAntipsychotic agents
dc.subject.meshElectrocardiography
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshPiperazines
dc.subject.meshThiazoles
dc.subject.scopusNeuroleptic Agent; Prolongation; Ziprasidone
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.subject.wosPharmacology & pharmacy
dc.subject.wosPsychiatry
dc.titleThe potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases
dc.typeArticle
dc.wos.quartileQ1
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Psikiyatri Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications